Citation Impact
Citing Papers
Fat Metabolism Links Germline Stem Cells and Longevity in C. elegans
2008 StandoutScienceNobel
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Major Depressive Disorder and Inflammatory Markers in Elderly Patients With Heart Failure
2007
Depression and Inflammation in Patients With Coronary Heart Disease: Findings from the Heart and Soul Study
2007
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
Homocysteine and vascular disease
1999 Standout
High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania
2006
Heparin-Protein Interactions
2002 Standout
TLR4 Polymorphisms and Ageing: Implications for the Pathophysiology of Age-Related Diseases
2009
Pioglitazone and cardiovascular risk. A comprehensive meta‐analysis of randomized clinical trials
2008
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation
2002 StandoutNobel
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
2009 Standout
Regulation of angiotensin II type 1 (AT1) receptor function
1999
Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women
1995
HDL particle size: a marker of the gender difference in the metabolic risk profile
2002
Relation of Social Integration to Inflammatory Marker Concentrations in Men and Women 70 to 79 Years
2006
The metabolic syndrome
2010 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction
1993
Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C
1993
A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population
1995
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway
1999 StandoutNobel
Metabolic origins and clinical significance of LDL heterogeneity
2002
Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
1992 StandoutNature
Diabetic dyslipidaemia: from basic research to clinical practice*
2003
Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?
2002
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
2004 StandoutNobel
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
The Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Coronary Artery Vasoconstriction
1997
Association Between Major Depressive Episodes in Patients With Chronic Kidney Disease and Initiation of Dialysis, Hospitalization, or Death
2010
Molecular biology of angiotensin receptors and their role in human cardiovascular disease
1996
Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease
1997
Premature cardiovascular disease in chronic renal failure
2000
Protection by β-carotene and related compounds against oxygen-mediated cytotoxicity and genotoxicity: Implications for carcinogenesis and anticarcinogenesis
1992
A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension
1997
Subjective wellbeing, health, and ageing
2014 StandoutNobel
Depression, Inflammation, and Incident Cardiovascular Disease in Women With Suspected Coronary Ischemia
2007
Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension
1998
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
1993 Nature
Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells
1999 StandoutNobel
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Cardiac-related Hospitalization and/or Death Associated With Immune Dysregulation and Symptoms of Depression in Heart Failure Patients
2007
Atherosclerosis
2000 StandoutNature
Stable Interaction between β-Arrestin 2 and Angiotensin Type 1A Receptor Is Required for β-Arrestin 2-mediated Activation of Extracellular Signal-regulated Kinases 1 and 2
2004 StandoutNobel
Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease
1996
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
The Emergence of the Metabolic Syndrome with Menopause
2003
Homocysteine and atherosclerosis
1999
Atherosclerosis
2001 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Control of cell fates in the central body region of C. elegans by the homeobox gene lin-39
1993 StandoutNobel
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated with an Increased Vascular Reactivity in the Human Mammary Artery in vitro
1998
Blood Pressures and Cardiovascular Homeostasis in Mice Having Reduced or Absent Angiotensin-Converting Enzyme Gene Function
1997 StandoutNobel
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
2008
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Splicing in Caenorhabditis elegans does not require an AG at the 3' splice acceptor site.
1993
Angiotensin-Converting Enzyme Gene Polymorphism Has No Influence on the Circulating Renin-Angiotensin-Aldosterone System or Blood Pressure in Normotensive Subjects
1995
Angiotensin II Type 1 Receptor A/C 1166 Polymorphism
1996
Lipoprotein lipase mutations and Alzheimer's disease
1999
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Gene Polymorphism but not Catalytic Activity of Angiotensin I–Converting Enzyme Is Associated With Coronary Artery Disease and Myocardial Infarction in Low-Risk Patients
1995
BIOLOGICAL FUNCTIONS OF ANGIOTENSIN AND ITS RECEPTORS
1997
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Very-Low-Density Lipoprotein Response Element in the Promoter Region of the Human Plasminogen Activator Inhibitor-1 Gene Implicated in the Impaired Fibrinolysis of Hypertriglyceridemia
1998
Depression and Coronary Heart Disease
2008 Standout
Angiotensin-Converting Enzyme Gene and Atherosclerosis
1997 StandoutNobel
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression
1999
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
2003
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
1996
Genetic Modifiers of Atherosclerosis in Mice
2000
Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
1998 StandoutNobel
Genetic Dissection of Complex Traits
1994 StandoutScience
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Coronary Plaque Disruption
1995 Standout
Homocysteine and Cardiovascular Disease
1998 Standout
Angiotensin-Converting Enzyme Gene Mutations, Blood Pressures, and Cardiovascular Homeostasis
1997 StandoutNobel
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
A Meta-analysis of the Association of the Deletion Allele of the Angiotensin-Converting Enzyme Gene With Myocardial Infarction
1996
Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
1998
Works of G. Luc being referenced
Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde
1996
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study
1996
The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients
2006
Oxidation of lipoproteins and atherosclerosis
1991
High-density lipoprotein particles in octogenarians
1991
Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease
1996
Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction
1994
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study
2004
Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.
1995
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study.
1993
Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes
1996
Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.
1994
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
1996
Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men
2005
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study.
1994
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.
1992
The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study
1995
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene.
1990